Heat treatment could bring leishmaniasis care to local clinics

NCT ID NCT06746350

Recruiting now Disease control Sponsor: Armauer Hansen Research Institute, Ethiopia Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a device that heats skin lesions to 50°C for 30 seconds can effectively treat cutaneous leishmaniasis in primary health centers in Ethiopia. 103 patients aged 12 to 60 with up to four lesions will receive thermotherapy and be monitored for 90 days. The goal is to see if this simple heat treatment is practical, acceptable, and effective in a real-world setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Thermotherapy (heat treatment using ThermoMed device at 50°C for 30 seconds)
What this could lead to: If successful, this could show that heat therapy is a practical and effective way to treat skin leishmaniasis in local clinics, making treatment more accessible.
What could go wrong: This is a small feasibility study, not a large trial. The treatment may not work as well in real-world settings, and some patients may need repeat treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS LEISHMANIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous leishmaniasis Hyperthermia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CUTANEOUS LEISHMANIASIS

Contacts and locations

Locations

CDT-Africa
RECRUITING

Addis Ababa, Ethiopia

More trials for these conditions

Other studies related to the condition(s) this trial covers.